Cordis Corp. introduced next generation carotid stent system, the PRECISE PRO RX Nitinol Self-Expanding Stent, designed to treat clogged neck arteries and enable more efficient manipulation of the catheter and guidewire during stenting procedures and better crossability.
October 24, 2007 — Drug-eluting balloons could offer a viable alternative to drug-eluting stents (DES) in the treatment of coronary artery disease, according to research results from two studies presented today at TCT 2007, in which one of the studies marked the first direct comparison between DES and drug eluting balloons.
October 25, 2007 - Early intervention saves lives in women who have a heart attack or unstable chest pain, according to research presented at TCT 2007, information that counters reports suggesting women do not fare as well as men following angioplasty.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 25, 2007 – Ceremed's Ostene, designed to stop bone bleeding in surgery, reportedly does not interfere with bone ...
October 25, 2007 - Paieon Inc. demonstrated at TCT 2007 the CardiOp-StentOptimizer, a real-time imaging solution ...
October 24, 2007 - Presented at the TCT 2007 meeting, a pooled analysis of safety data from Medtronic’s ENDEAVOR ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 25, 2007 - Study results presented at TCT 2007 demonstrated that the use of the isosmolar contrast medium ...
October 24, 2007 – ev3 Inc. highlighted at TCT 2007 its merger with FoxHollow Technologies, Inc., which created an organization that possesses one of the largest U.S. distribution footprints in endovascular devices with combined technologies for the advancement of the treatment of peripheral and neurovascular disease.
October 22, 2007 – A time-motion study conducted at Providence Heart Institute in Columbia, SC, spanning approximately ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced ...
October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.
October 23, 2007 - Toshiba America Medical Systems Inc. today announced that the first U.S. installation of the Infinix ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 23, 2007 - ENDEAVOR IV reached its primary endpoint of target vessel failure non-inferiority when compared to ...
OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...
October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy ...